The Correlation Between Lipid Profile and Xanthelasma
Downloads
Background: Xanthelasma is an abnormal lipid deposition on palpebrae, which is observable as yellowish plaque or nodules. Its incidence is 0.56–1.5% with onset of 15–73 years old and mostly occurs in the fourth and fifth decade. Few reports of xanthelasma did not cover the correlation between lipid profile and xanthelasma in Indonesia. Purpose: To find a correlation between lipid profile with xanthelasma in Dr. M. Djamil Hospital, Padang. Methods: This was an analytic cross-sectional study with consecutive sampling. There were 36 participants (18 xanthelasma and 18 control). Result: The highest age group was >36 - ≤45 years old (38.89%). More cases were observed in female (66.67%). Body mass index examination of xanthelasma revealed that most were overweight (55.56%). Grade I xanthelasma was the most common (72.22%). The cholesterol serum level of xanthelasma patients was higher than the subject controls (224.61±29.77 mg/dl versus 169.39±35.84 mg/dl) (p<0,05). The High Density Lipoprotein (HDL) serum level of xanthelasma patients was lower than controls (46.44±14.19 mg/dl versus 51.78±15.9 mg/dl) (p>0,05). The Low Density Lipoprotein (LDL) serum level of xanthelasma patients was higher than control (139.39±29.73 mg/dl versus 106.50±35.43 mg/dl) (p<0,05). Triglyceride serum level of xanthelasma patients was higher than the controls (167.83±87.26 mg/dl versus 121.61±54.52 mg/dl) (p>0,05). Conclusion: There was a correlation between higher cholesterol and LDL serum level with xanthelasma. No correlation between lower HDL and a higher triglyceride serum level with xanthelasma.
Schaefer EJ, Santos RD. Xanthomatoses and lipoprotein disorders. In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p. 1600-12.
Wulandari N, Nilasari H, Cipto H. Xantelasma, gambaran klinis dan penatalaksanaan. MDVI 2013; 40(1): 46-55.
Sharma P, Patgiri D, Sharma G, Pathak MS. Serum lipid profile in xanthelasma palpebrum. Indian Journal of Basic and Applied Medical Research 2013;7(2): 732-7.
Dey A, Aggarwal R, Dwivedi S. Cardiovascular profile of xanthelasma palpebrarum. BioMed Research International 2013: p. 1-3.
Greijmans E, Welkenhuyzen HL, Luijks H, Bovenschen HJ. Continuous wave potassium titanyl phosphate laser treatment is safe and effective for xanthelasma palpebrarum. American Society for Dermatologic Surgery 2016; 42: 860–6.
Nair PA, Singhai R. Xanthelasma palpebrarum-A brief review. Clinical, Cosmetic and Investigational Dermatology 2018; 11: 1-5.
Bergman R, Friedman-Birnbaum R, Aviram M, Katz I, Kerner H, Brook J. Adult xanthogranulomatosis associated with abnormal apolipoprotein levels. Clinical Experimental Dermatology 1990;15: 372-5.
Sharma SB, Dwivedi S, Prabhu KM, Kumar N, Baruah MC. Preliminary studies on serum lipids, apolipoprotein-B and oxidative stress in xanthelasma. Indian Journal of Clinical Biochemistry 1999; 14(2): 245-8.
Laftah Z, Al-Niaimi F. Xanthelasma: An update on treatment modalities. Journal of Cutaneous and Aesthetic Surgery 2018; 11(1): 1-6.
Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: Clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2014; 158(2): 181-8.
Jung SY, Hwang NH, Yoon ES, Park SH. Erbium: Yttrium aluminum garnet laser treatment for xanthelasma palpebrarum. Medical Lasers; Engineering, Basic Research, and Clinical Application 2017; 6(1): 24-8.
Jonsson A, Sigfusson N. Significance of xanthelasma palpebrarum in the normal population. Lancet 1976; 372-4.
Segal P, Insull W J, Chambless LE. The association of dyslipoproteinemia with corneal arcus and xanthelasma. Circulation 1986; 1108-18.
Roederer GO, Bouthillier 0, Davignon J. Xanthelasma palpebrarum and corneal arcus in octogenarians. N Engl J Med 1987; 1740.
Hidajat D, Hapsari Y, Hendrawan IW. Karakteristik penyakit kulit pada geriatri di Poliklinik kulit dan kelamin RSUD Provinsi Nusa Tenggara Barat periode 2012-2014. Jurnal Kedokteran Universitas Mataram 2017; 6(4): 7-13.
Zagoto YES, Lestari S, Asri E. Profile of xanthelasma during Januari 2014-December 2017 in Dermato-Venereology outpatient clinic of Dr. M. Djamil hospital Padang. Regional Confrence of Dermatology 2018. Surabaya, Indonesia.
Aggarwal R, Rathore PK. A study evaluating xanthelasma palpebrarum clinically and biochemically. International Journal of Contemporary Medical Research 2016; 3(9): 2565-7.
Kavoussi. Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum. An Bras Dermatol 2016; 468-71.
Pandhi D, Gupta P, Singal A, Tondon A, Sharma SB, Madhu SV. Xanthelasma palpebrarum: A marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). Postgrad Med J 2012; 88: 198-204.
Özdöl S, Sahin S, Tokgözoglu L. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a). The International Society of Dermatology International Journal of Dermatology 2008; 47: 785–9.
Dwivedi S, Aggarwal A, Singh S, Sharma V. Familial xanthelasma with Dyslipidemia: Just Another Family Trait?. North American Journal of Medical Sciences 2012; 4: 238-40.
Sarkany RPE, Breathnach SM, Seymour CA, Weismann K, Burns DA. Metabolic and nutritional disorders. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's textbook of dermatology. 7th ed. Massachusetts: Blackwell Science; 2004. p. 57.66.
James WD, Berger TG, Elston DM. Andrews's diseases of the skin clinical dermatology. 9th ed. Canada : Elsevier Incorporation; 2009. p.528-32.
Jain A, Goyal P, Nigam PK, Gurbaksh H, Sharma RC. Xanthelasma palpebrarum: Clinical and biochemical profile in a tertiary care hospital of Delhi. Indian Journal of Clinical Biochemistry 2007; 22(2): 151-3.
Caputo R, Monti M, Berti E. Normolipemic eruptive cutaneous xanthomatosis. Arch Dermatol 1986; 122: 1294-7.
Christoffersen M, Schmidt RF, Schnohr P, Jensen GB, Nordestgaard BG, Hansen AT. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. British Medical Journal 2011(343): 731-5.
Arifah. Peran lipoprotein dalam pengangkutan lemak tubuh. Ed Arifah. Dalam Kaunia Jakarta: EGC; 2006. p. 121-34.
Santoso A. PERKI. Pedoman tatalaksana dislipidemia. Jakarta: Centra Communications; 2013. p. 5-27.
Turgeon RD, Anderson TJ, Gregoire J, Pearson GJ. 2016 Guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacist. Canadian Journal Cardiology 2016; 32: 1263-82.
Noí«l B. Premature atherosclerosis in patients with xanthelasma. Journal of European Academy of Dermatology and Venereology 2007; (21): 1244–8.
Szalat R. Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy. The Am Soc of Hem 2011; 3777-83.
Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol 1994; 30: 236-42.
Akyuz AR. Xanthelasma is associated with an increase amounth of epicardial adipose tissue. Med Princ Pract 2016; 25(2): 187-90.
Ana, Jonas. Lipoprotein structure. USA: Elsevier science; 2002. p. 32-9.
Erwinanto. PERKI. Pedoman tatalaksana dyslipidemia. 2013. p. 37-51.
Sniderman A, Couture P, Graaf Jd. Nature Review. Endocrinololy 2010; 6: 335–46.
Esmat. Risk of atherosclerosis in normolipidaemic patients with xanthelasma. Clinical and Experimental Dermatology 2015; 40: 373–8.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
